ARCHIVES

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

Letter: ORI And Plotkin Should Release Report

June 23, 1995

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

John Durant Is Chosen “Cancer Fighter of the Year”.

May 17, 2002